Want to track ATNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 87 days
Actinium Pharma's stock craters after FDA says Phase 3 trial of leukemia treatment not enough for BLA
The stock of biotech Actinium Pharmaceutics Inc. tumbled 65% early Monday, after the Food and Drug Administration said a late-stage trial of its Iomab-B leukemia treatment is not enough to support a request for approval.
Marketwatch | 1 year ago
3 Under-$10 Biotech Stocks That Could Make You Rich
Low-cap biotech companies are a high-risk but high-reward investment choice. If their clinical trials are successful, that can often mean an explosion in value as investors anticipate a buyout.
Investorplace | 1 year ago
Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?
Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.
Zacks | 1 year ago
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
In a meme frenzy, any positive news related to a company has a magnified impact on the stock price. In the euphoria of 2021, companies with ambitious growth plans skyrocketed.
Investorplace | 1 year ago
